Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1078 of 3330
Next
>>
>
26926 to 26950 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
184A1	NM	Basal	FTase Inhibitor I	Ftase	MAPK	2.67	uM	12509.167	1.0055	1.0077	1.4256
184A1	NM	Basal	FTase Inhibitor I	Ftase	MAPK	13.3	uM	12509.167	0.9991	0.9988	1.4256
184A1	NM	Basal	FTase Inhibitor I	Ftase	MAPK	66.7	uM	12509.167	1.0388	1.0541	1.4256
184B5	NM	Basal	FTase Inhibitor I	Ftase	MAPK	0.000171	uM	12566.167	1.0029	1.0036	1.5941
184B5	NM	Basal	FTase Inhibitor I	Ftase	MAPK	0.000853	uM	12566.167	1.0041	1.0051	1.5941
184B5	NM	Basal	FTase Inhibitor I	Ftase	MAPK	0.00427	uM	12566.167	1.0101	1.0127	1.5941
184B5	NM	Basal	FTase Inhibitor I	Ftase	MAPK	0.0213	uM	12566.167	1.0044	1.0055	1.5941
184B5	NM	Basal	FTase Inhibitor I	Ftase	MAPK	0.107	uM	12566.167	1.0135	1.0169	1.5941
184B5	NM	Basal	FTase Inhibitor I	Ftase	MAPK	0.533	uM	12566.167	0.9887	0.9858	1.5941
184B5	NM	Basal	FTase Inhibitor I	Ftase	MAPK	2.67	uM	12566.167	1.0192	1.0240	1.5941
184B5	NM	Basal	FTase Inhibitor I	Ftase	MAPK	13.3	uM	12566.167	0.9742	0.9675	1.5941
184B5	NM	Basal	FTase Inhibitor I	Ftase	MAPK	66.7	uM	12566.167	0.9579	0.9467	1.5941
600MPE	HR+	Luminal	FTase Inhibitor I	Ftase	MAPK	0.0000853	uM	12224.154	1.0493	1.1030	0.9590
600MPE	HR+	Luminal	FTase Inhibitor I	Ftase	MAPK	0.000427	uM	12224.154	0.9557	0.9076	0.9590
600MPE	HR+	Luminal	FTase Inhibitor I	Ftase	MAPK	0.00213	uM	12224.154	0.9754	0.9487	0.9590
600MPE	HR+	Luminal	FTase Inhibitor I	Ftase	MAPK	0.0107	uM	12224.154	0.9385	0.8719	0.9590
600MPE	HR+	Luminal	FTase Inhibitor I	Ftase	MAPK	0.0533	uM	12224.154	0.9594	0.9154	0.9590
600MPE	HR+	Luminal	FTase Inhibitor I	Ftase	MAPK	0.267	uM	12224.154	0.9806	0.9595	0.9590
600MPE	HR+	Luminal	FTase Inhibitor I	Ftase	MAPK	1.33	uM	12224.154	0.9938	0.9871	0.9590
600MPE	HR+	Luminal	FTase Inhibitor I	Ftase	MAPK	6.67	uM	12224.154	0.9821	0.9626	0.9590
600MPE	HR+	Luminal	FTase Inhibitor I	Ftase	MAPK	33.3	uM	12224.154	0.9030	0.7982	0.9590
AU565	HER2amp	Luminal	FTase Inhibitor I	Ftase	MAPK	0.0000853	uM	10880.154	0.9338	0.9247	1.7853
AU565	HER2amp	Luminal	FTase Inhibitor I	Ftase	MAPK	0.000427	uM	10880.154	0.9513	0.9448	1.7853
AU565	HER2amp	Luminal	FTase Inhibitor I	Ftase	MAPK	0.00213	uM	10880.154	0.9539	0.9478	1.7853
AU565	HER2amp	Luminal	FTase Inhibitor I	Ftase	MAPK	0.0107	uM	10880.154	0.9327	0.9235	1.7853

|<
<<
Previous
Page 1078 of 3330
Next
>>
>
26926 to 26950 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)